These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 33429327

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition.
    Yan X, Hong B, Feng J, Jin Y, Chen M, Li F, Qian Y.
    BMC Cancer; 2022 Oct 10; 22(1):1053. PubMed ID: 36217128
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
    Xie N, Cai JB, Zhang L, Zhang PF, Shen YH, Yang X, Lu JC, Gao DM, Kang Q, Liu LX, Zhang C, Huang XY, Zou H, Zhang XY, Song ZJ, Sun HX, Fu BM, Ke AW, Shi GM.
    Cell Death Dis; 2017 Dec 13; 8(12):3205. PubMed ID: 29235470
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BTF3-mediated regulation of BMI1 promotes colorectal cancer through influencing epithelial-mesenchymal transition and stem cell-like traits.
    Zhou W, Yun Z, Wang T, Li C, Zhang J.
    Int J Biol Macromol; 2021 Sep 30; 187():800-810. PubMed ID: 34293363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. B7-H4 expression promotes non-small cell lung cancer progression via AMPK/mTOR signaling.
    Li M, Che N, Feng Y, Liu X, Piao L, Xuan Y, Jin Y.
    Exp Mol Pathol; 2022 Apr 30; 125():104755. PubMed ID: 35278461
    [Abstract] [Full Text] [Related]

  • 13. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY, Kaf RM, Ahmed MM, Elwan A, Ashour HR, Ibrahim A.
    J Gastrointest Cancer; 2019 Dec 30; 50(4):824-837. PubMed ID: 30136202
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z, Wu D, Chen Y, Min Z, Quan Y.
    Cancer Biol Ther; 2019 Dec 30; 20(9):1195-1205. PubMed ID: 31063022
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
    Liu YP, Zhu HF, Liu DL, Hu ZY, Li SN, Kan HP, Wang XY, Li ZG.
    Oncotarget; 2016 Nov 22; 7(47):77306-77318. PubMed ID: 27764793
    [Abstract] [Full Text] [Related]

  • 20. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism.
    Lu YX, Yuan L, Xue XL, Zhou M, Liu Y, Zhang C, Li JP, Zheng L, Hong M, Li XN.
    Clin Cancer Res; 2014 May 15; 20(10):2631-42. PubMed ID: 24658157
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.